Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union Driven by positive ...
New clinical data to be presented on VIMPAT® (lacosamide) as early adjunctive therapy for partial-onset seizures in adults Scientific data ...
This first-time, real-world study of an online health management platform demonstrated statistically significant improvements in established epilepsy metrics of patient ...
UCB and Biogen Idec announced that they have signed exclusive agreements granting UCB the right to commercialize Biogen Idec products ...
Underlying profitability (recurring EBITDA) reached EUR 319 million (-12%) due to product mix and high R&D expenses of EUR 424 ...
WILEX will be reimbursed an undisclosed amount for its development costs to date and shall be eligible for future, undisclosed ...
The research alliance between LIBD and UCB reflects UCB’s “open innovation” approach that aims to generate new knowledge and capitalize ...
MAM Telecom Ltd , an existing participant in FasterCapital ’s EquityPilot program, today reported progress on multiple operational fronts in...
Read moreDetails
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.
